Skip to main content

Table 1 Patient (n = 301) and lesion (n = 387) characteristics; percentages are given per SBRT treatment

From: Safety and efficacy of stereotactic body radiotherapy as primary treatment for vertebral metastases: a multi-institutional analysis

Characteristic

Median

Range

Proportion (%)

Age (years)

61.3

9 - 91

 

Performance status

90

40 - 100

 

Sex (male)

  

55.1

Interval PD to SBRT (years)

2.5

0 - 41

 

Primary disease

   

 Breast

  

20

 RCC

  

19

 NSCLC

  

16

 Other

  

45

Pain prior to SBRT

   

 No

  

18.2

 Yes

  

81.8

Solitary metastasis (yes)

  

23.0

Systemic disease considered as controlled prior to SBRT (yes)

  

32.0

Cancer treated with curative intend at primary diagnosis (yes)

  

67.7

Additional bone metastasis (present)

  

62.9

Visceral metastases (present)

  

42.3

Bilsky Score 0 (yes)

  

41.8

Paraspinal involvement of spine metastasis (yes)

  

44.8

Osteolytic component of spine metastasis (yes)

  

72.3

Compression fracture of spine metastasis (yes)

  

19.8